Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1371 studies found for:    "Liver Neoplasms"
Show Display Options
Rank Status Study
21 Withdrawn Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Condition: Liver Neoplasms
Intervention: Drug: Temsirolimus 25mg and Pegylated liposomal doxorubicin 25mg/m2
22 Completed Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors
Condition: Malignant Liver Tumors
Interventions: Procedure: irreversible electroporation;   Device: nanoknife  AngioDynamics US Ltd
23 Completed Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer
Condition: Liver Neoplasms
Interventions: Device: Microwave ablation;   Device: Radiofrequency ablation
24 Completed A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
Conditions: Liver Neoplasms;   Neoplasm Metastasis
Interventions: Procedure: Isolated hepatic portal and arterial perfusion;   Drug: Melphalan
25 Completed A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
Conditions: Colorectal Neoplasm;   Liver Neoplasm;   Neoplasm Metastasis
Interventions: Drug: Melphalan;   Drug: Floxuridine;   Drug: Leucovorin
26 Completed Chemotherapy in Treating Children With Liver Cancer
Condition: Liver Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Procedure: conventional surgery
27 Recruiting Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)
Condition: Liver Cancer
Interventions: Procedure: Electrochemotherapy;   Device: Cliniporator Vitae®;   Drug: Bleomycin PHC 15 e. (United States Pharmacopeia - USP)
28 Completed Taxoprexin® Treatment for Advanced Primary Cancers of the Liver
Condition: Cancer of the Liver
Intervention: Drug: Taxoprexin
29 Completed Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
Conditions: Liver Cancer;   Metastatic Cancer
Intervention: Procedure: Radiofrequency Ablation
30 Unknown  Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Intervention: Drug: antineoplaston A10
31 Terminated IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
Conditions: Cancer of the Liver;   Liver Cancer;   Hepatoma;   Liver Neoplasms;   Biliary Cancer
Intervention: Biological: Salmonella typhimurium
32 Withdrawn Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
Condition: Liver Cancer
Interventions: Genetic: comparative genomic hybridization;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: proteomic profiling;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: medical chart review
33 Recruiting Microwave Ablation of Resectable Liver Tumors
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Intervention: Device: Microwave Ablation
34 Completed A Phase I Study of Pazopanib in Adult Patients With Liver Cancer
Conditions: Carcinoma, Hepatic Cell;   Liver Cancer
Intervention: Drug: pazopanib
35 Completed
Has Results
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
Condition: Liver Cancer
Intervention: Drug: lenalidomide
36 Completed Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
Conditions: Colorectal Cancer;   Islet Cell Tumor;   Liver Cancer;   Metastatic Cancer;   Neuroendocrine Carcinoma
Interventions: Drug: isolated perfusion;   Drug: melphalan;   Procedure: conventional surgery
37 Completed A Retrospective Review of Malignant Liver Tumors
Condition: Liver Cancer
Intervention:
38 Withdrawn SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: lonafarnib;   Procedure: conventional surgery
39 Completed Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed
Condition: Liver Cancer
Interventions: Biological: recombinant interferon alfa;   Drug: thalidomide
40 Completed Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases
Conditions: Liver Cancer;   Metastatic Cancer
Intervention: Procedure: cryosurgery

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years